ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks”

May 13, 1988

MSK Starts Ovarian Cancer Program

November 21, 1986

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Hammer to Produce US-USSR “Cancer Summit” March 29

March 25, 1988

House panel examines use of grant funds.

September 23, 2005